发布: 2019年09月05日第9卷第17期 DOI: 10.21769/BioProtoc.3356 浏览次数: 3923
评审: Vivien Jane Coulson-ThomasPaul Ross Wildermantarsis ferreira
相关实验方案
通过CRISPR-Cas9介导的HiBiT标签对高度同源蛋白水平进行异构体特异性半定量测定
Kristina Seiler [...] Mario P. Tschan
2023年07月20日 1534 阅读
Abstract
Heparanase, an endo-β-D-glucuronidase, cleaves cell surface and extracellular matrix heparan sulfate (HS) chains at distinct sites and plays important biological roles including modulation of cell growth and metastasis. Although a number of different types of heparanase assays have been reported to date, most are labor intensive, complex and/or expensive to carry out. We reasoned that a simpler heparanase assay could be developed using heparin labeled with Dabcyl and EDANS as donor and acceptor fluorophores so as to generate a FRET signal. Our results show that a more robust heparanase assay could be developed based on the principle studied herein and more homogeneous preparation of heparin. Yet, the assay in its current form could be used for routine screening of potential inhibitors in a high-throughput manner as well as for studying heparanase activity expressed in tumors as well as biological fluids like plasma.
Keywords: Heparanase (乙酰肝素酶)Background
Human heparanase is an endo-β-D-glucuronidase that cleaves heparan sulfate (HS) chains present in proteoglycan form on cell surfaces and in the extracellular matrix (Fairbanks et al., 1999; Kussie et al., 1999; Toyoshima and Nakajima, 1999; Dempsey et al., 2000; Sanderson et al., 2017). Although other sequences are also likely to be targeted by heparanase (Peterson and Liu, 2013), substrate specificity studies indicate that heparanase preferably cleaves the 1→4-inter-glycosidic bond between a glucuronic acid (GlcA) and glucosamine-N,6-disulfate (GlcNS6S) residues.
The importance of heparanase as a therapeutic target has led to the development of several biochemical and biophysical assays over the past 2 decades. Despite the availability of numerous assays, no particular assay appears to have been broadly used to understand heparanase biology, pharmacology, and drug discovery. The reported assays typically suffer from the involvement of multiple steps and incubation up to 24 h (Freeman and Parish, 1997; Behzad and Brenchley, 2003; Tsuchida et al., 2004; Enomoto et al., 2006; Hammond et al., 2010; Schiemann et al., 2012; Melo et al., 2015). An easier, one-step assay would greatly help deduce inhibitors, understand substrate specificity, elucidate the mechanism of action, and clarify enzymatic or non-enzymatic role in cellular systems. A more robust heparanase assay would be easier to implement (fewer steps, faster screening time, no immobilization, no post-assay signal development), which is adaptable to microplate format, enable assaying active heparanase in cellular media, and perhaps help monitor heparanase in vivo. We hypothesized fluorescence resonance energy transfer (FRET)-based assay may offer a one-step solution that can address several attributes. This documents, method of developing a FRET-based assay for active heparanase. Based on our work, FRET-enabled heparin chain could effectively serve as a substrate of heparanase, help detect an active enzyme in media, and to screen potential inhibitors.
Materials and Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2019 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Sistla, J. and Desai, U. R. (2019). A Robust, One-step FRET Assay for Human Heparanase. Bio-protocol 9(17): e3356. DOI: 10.21769/BioProtoc.3356.
分类
癌症生物学 > 通用技术 > 生物化学试验
生物化学 > 糖类 > 寡糖
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link